A drug is available for monkeypox patients who have or who are at risk of severe disease, but doctors say they continue to face challenges getting access to it. The U.S. Food and Drug Administration hasn't approved tecovirimat -- sold under the brand name Tpoxx -- specifically for use against monkeypox, but the U.S. Centers for Disease Control and Prevention has made the drug available.

Source: CBC News August 01, 2022 20:15 UTC